Table 1.
Study | Cohort | n | Locus | Marker | LOD | p | Gene(s) |
---|---|---|---|---|---|---|---|
Singh, 2017 [100] | LLFS | 3876 | 1p13.3 | rs201856309 | – | 1.67E-09 | NBPF6; NBPF5 |
Pilling, 2017 [98] | UKB | 389,166 | Chr 1 | rs602633 | – | 2.7E–08 | CLESR2 … PSRC1 |
Chr 1 (rare) | rs146254978 | – | 4.6E–08 | FPGT/TNNI3K | |||
Singh, 2017 [100] | LLFS | 3876 | 2p22.1 | rs116083259 | – | 1.17E-08 | CAPN9; C1ORF |
Boyden, 2010 [101] | NECS | 279 sibs | 3p24.2–22.3 | rs28150 | 4.02 | – | TOP2B |
Puca, 2001 [102] | Boston | 137sibs | 4q25 | D4S1564 | 3.26 | – | – |
Sebastiani, 2017 [97] | MCCb | 8329 | 4q25 | rs28391193 | – | 2.0E–07 | ELOVL6 |
Deelen, 2014 [92] | MCCa | 23,850 | 5q33.3 | rs2149954 | – | 1.7E-08 | EBF1 |
(6 repl) | |||||||
Edwards, 2011 [103] | CAMP | 263 ped | Chr 6 | rs1409014 | 4.49 | – | BMP5 |
Edwards, 2013 [104] | CAMP | 263 ped | 6q25–27 | rs1247322 | 3.2 | – | PLG/MAP3K4 |
−rs1247363 | |||||||
6q25–27 | rs16892673 | 3.2 | – | PARK2 | |||
−rs16892700 | |||||||
Broer, 2015 [93] | CHARGE | 9793 | Chr 6 | rs2802292 | – | 1.85E–10 | FOXO3 |
McDaid, 2017 [96] | UKB | 116,279 | Chr 6 | rs10455872 | – | 1.60E-08 | LPA |
(5 repl) | |||||||
Pilling, 2017 [98] | UKB | 389,166 | Chr 6 | rs28383322 | – | 5.3E–11 | HLA-DRB1…HLA-DQA1 |
Chr 6 | rs55730499 | – | 1.7E–18 | LPA | |||
Chr 6 | rs1627804 | – | 4.0–08 | BEND3 | |||
Chr 6 (F) | rs3130507 | – | 2.1E–10 | PSORS1C3 … | |||
Chr 6 (M) | rs3131621 | – | 3.6–08 | MICA … MICB | |||
Joshi, 2017 [74] | UKB, | 606,059 | Chr 6 | rs55730499 | – | 8.67E–11 | LPA |
CHARGE-EU | rs34831921 | – | 4.18E–08 | HLA-DQA1/DRB1 | |||
Edwards, 2011 [103] | CAMP | 263 ped | Chr 7 | rs517258 | 3.11 | – | – |
Pilling, 2016 [105] | UKB | 75,224 | Chr 7 | rs528161076 | – | 3.40–08 | AP5Z1 |
Zeng, 2016 [106] | CLHLS | 4965 | Chr 7 | rs2069837 | – | 4.05E-08 | IL6 |
(4 repl) | |||||||
Sebastiani, 2017 [97] | MCCb | 8329 | Chr 7 | rs3764814 | – | 5.00–15 | USP42 |
(2 repl) | |||||||
Beekman, 2013 [91] | GEHA | 2118 sibs | 8p11.21 | rs801100 | 3.61 | – | – |
−q13.1 (M) | rs4368961 | ||||||
Pilling, 2017 [98] | UKB | 389,166 | Chr 8 | rs7844965 | – | 7.7E–09 | EPHX2 |
Chr 8 (M) | rs13262617 | – | 3.1E–08 | TOX | |||
Boyden, 2010 [101] | NECS | 279 sibs | 9q31.3–34.2 | rs536861 | 3.89 – | TLR4; DBC1 | |
Minster, 2015 [107] | LLFS | 3140 sibs | 9p24.2 | – | 3.36 | – | – |
(2 repl) | p23 (F) | ||||||
Pilling, 2016 [105] | UKB | 75,224 | Chr 9 | rs75824829 | – | 4.00–08 | C9orf62 |
McDaid2017 [96] | UKB | 116,279 | Chr 9 | rs1333045 | – | 1.77E-08 | CDKN2B-AS1 (ANRIL) |
(5 repl) | |||||||
Pilling, 2017 [98] | UKB | 389,166 | Chr 9 | rs1556516 | – | 4.7E–16 | CDKN2B-AS1 (ANRIL) |
Singh2017 [100] | LLFS | 3876 | 10p15 | rs1019025 | – | 4.65–08 | KLF6 |
(1 repl) | |||||||
Pilling, 2017 [98] | UKB | 389,166 | Chr 11 (M) | rs61905747 | – | 5.5E–09 | ZW10 |
Chr 11 (rare) | rs139137459 | – | 2.7E–08 | USP2-AS1 | |||
Boyden, 2010 [101] | NECS | 279 sibs | 12q24.31–24.33 | rs1732462 | 4.05 | – | – |
Sebastiani, 2017 [97] | MCCb | 8329 | Chr 12 | rs7976168 | – | 4.00E-09 | TMTC2 |
(2 repl) | |||||||
Pilling, 2017 [98] | UKB | 389,166 | Chr 12 | rs7137828 | – | 3.4E–14 | SH2B3/ATXN2 |
Zeng2016 [106] | CLHLS | 4965 | Chr 13 | rs2440012 | – | 4.89E-08 | ANKRD20A9P |
(4 repl) | |||||||
Pilling, 2017 [98] | UKB | 389,166 | Chr 13 (F) | 13:31871514 | – | 4.7E–08 | B3GALTL |
Chr 13 (F) | rs61949650 | – | 2.9E–08 | (intergenic) | |||
Edwards2011 [103] | CAMP | 263 | Chr 14 | rs764602 | 4.17 | – | BMP4 |
Beekman, 2013 [91] | GEHA | 2118 sibs | 14q11.2 | rs10484218 | 3.47 | – | |
−rs977870 | |||||||
Pilling, 2017 [98] | UKB | 389,166 | Chr 14 | rs61978928 | – | 2.0E–08 | PROX2 |
Beekman, 2013 [91] | GEHA | 2118 sibs | 15q12– | rs1871009 | – | 3.16 | – |
q14 | rs580839 | ||||||
Joshi2016 [95] | UKB | 116,425 | 15q24 | rs10519203 | – | 4.80–11 | CHRNA3/5 |
(3 repl) | (M) | ||||||
Joshi, 2017 [74] | UKB, CHARGE-EU | 606,059 | Chr 15 | rs8042849 | – | 3.75E–14 | CHRNA3/5 |
Pilling, 2016 [105] | UKB | 75,224 | Chr 15c | rs1061730 | – | 3.00–08 | CHRNA3/5 |
McDaid, 2017 [96] | UKB | 116,279 | Chr 15 | rs951266 | – | 4.33–10 | CHRNA5 |
(5 repl) | |||||||
Pilling, 2017 [98] | UKB | 389,166 | Chr 15 | rs1317286 | – | 1.2E–26 | CHRNA3 |
Chr 15 | rs17514846 | – | 7.1E–10 | FURIN | |||
Chr 15 (M) | rs74011415 | – | 1.4E–08 | SEMA6D | |||
Beekman, 2013 [91] | GEHA | 2118 sibs | 17q12– | rs2429990 | 3.47 | – | – |
q22 | −rs12949910 | ||||||
Tanaka, 2016 [108] | HRS | 5716 | Chr 18 | rs35715456 | – | 2.89E-08 | SMAD7 |
(3 repl) | |||||||
Pilling, 2017 [98] | UKB | 389,166 | Chr 18 | rs28926173 | – | 2.3E–08 | MC2R |
Deelen, 2011 [52] | LLS | 2073 | 19q13.32 | rs2075650 | – | 3.39E-17 | TOMM40/APOE/APOC1 |
(2 repl) | |||||||
Nebel2011 [89] | German | 1848 | Chr 19 | rs440638 | – | 1.80–10 | TOMM40/APOE/APOC1 |
(2 repl) | |||||||
Sebastiani, 2012 [90] | NECS | 51141 | 19q13.32 | rs2075650 | – | 1.03E-08 | TOMM40/APOE/APOC1 |
(2 repl) | |||||||
Beekman, 2013 [91] | GEHA | 2118 sibs | 19p13.3 | rs432001 | 3.76 | – | – |
−13.11 | −rs919333 | ||||||
19q13.11 | rs7250748 | 3.57 | – | TOMM40/APOE/APOC1 | |||
q13.32 | −rs10403760 | ||||||
19q13.33– | rs1236093 | 4.97 | – | – | |||
q13.41 (M) | −rs1661965 | ||||||
Deelen, 2014 [92] | MCCa | 23,850 | 19q13.32 | rs4420638 | – | 3.4E-36 | TOMM40/APOE/APOC1 |
(6 repl) | |||||||
Broer, 2015 [93] | CHARGE | 9793 | Chr 19 | rs2075650 | – | 2.4E-10 | TOMM40/APOE/APOC1 |
Fortney, 2016 [94] | MCCd | 25,166 | Chr 19 | rs2075650 | – | 2.40E-13 | TOMM40/APOE/APOC1 |
(4 repl) | |||||||
Joshi, 2016 [95] | UKB | 116,425 | 19q13 (F) | rs429358 | – | 4.20E-15 | TOMM40/APOE/APOC1 |
(3 repl) | |||||||
Joshi, 2017 [74] | UKB CHARGE-EU | 606,059 | Chr 19 | rs429358 | – | 1.44E-27 | TOMM40/APOE/APOC1 |
McDaid, 2017 [96] | UKB | 116,279 | Chr 19 | rs4420638 | – | 4.33E-08 | TOMM40/APOE/APOC1 |
(5 repl) | |||||||
Pilling, 2017 [98] | UKB | 389,166 | Chr 19 | rs429358 | – | 1.4E–74 | APOE/APOC1 |
Chr 19 (M) | rs12461964 | – | 8.2–09 | EGLN2…CYP2A6 | |||
Chr 19 (M) | rs74444983 | – | 9.1E–09 | EXOC3L2...MARK4 | |||
Sebastiani, 2017 [97] | MCCb | 8329 | Chr 19 | rs6857 | – | 2.00E-27 | TOMM40/APOE/APOC1 |
(2 repl) | Chr 19 | rs769449 | – | 1.00E-23 | TOMM40/APOE/APOC1 | ||
Chr 19 | rs59007384 | – | 5.00E-15 | TOMM40/APOE/APOC1 | |||
Pilling, 2017 [98] | UKB | 389,166 | Chr 20 | rs610784 | – | 1.2E–10 | C20orfl87 |
Chr 20 | rs2273500 | – | 1.5E–08 | CHRNA4 |
Abbreviations in column 2: CAMP, Collaborative Aging and Memory Project; CHARGE, Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium; CLHLS, Chinese Longitudinal Health Longevity Survey; GEHA, Genetics of Healthy Aging in Europe; HRS, Health and Retirement Study; LLFS, Long Life Family Study; LLS, Leiden Longevity Study; MCC, multiple combined cohorts; NECS, New England Centenarian Study; UKB, UK Biobank. Other abbreviations: Sibs, number of siblings present in study; Rep, number of replication samples in stidy; Ped, pedigrees; M, found only in male subjects; F, found only in female subjects.
The respective MCC indicated:
Belfast Elderly Longitudinal Free-Living Aging Study, Calabria cohort, CEPH centenarian cohort, Chinese Longitudinal Healthy Longevity Surveys, Danish longevity study I and II, deCODE, Estonian Biobank, Genetics of Healthy Aging Study, German longevity study, Leiden 85-plus study, Newcastle 85 + Study, PROspective Study of Pravastatin in the Elderly at Risk, Rotterdam Study, TwinGene
New England Centenarian Study, 90PLUS Cohort.
Southern Italian Centenarian Study, Long Life Family Study, Longevity Gene Project, New England Centenarian Study. cSouthern Italian Centenarian Study, Long Life Family Study, Longevity Gene Project, New England Centenarian Study.
35 other variants were genome-wide significant; rs1051730 deemed most significant by the authors owing to its previous link to lower smoking and lung cancer risk.
If two genes are separated by dots the SNP is intergenic.
Parts of this Table were adapted from Hook et al. [109].